Vertex Pharmaceuticals stock rises as FDA approves its pain pill

2 days ago · Vertex Pharmaceuticals stock rose on Friday after the Food and Drug Administration (FDA) approved its new ... “With the approval of Journavax, a non-opioid, pain signal inhibitor …

CouponFollow Extension

13%
OFF

Vertex Surges On FDA Approval Of Groundbreaking Pain …

3 weeks from now

3 days ago · Vertex Pharmaceuticals Inc. (VRTX) saw its stock surge by $35.63 or 8.13% in after-hours trading on Thursday following the U.S. Food and Drug Administration's approval of …

wallstreetpit.com

31%
OFF

Vertex Pharmaceuticals Just Won A Huge FDA Approval. Is The …

3 weeks from now

1 day ago · Vertex Pharmaceuticals (VRTX 5.31%) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 days. On Dec. 20, 2024, the FDA gave a thumbs-up …

fool.com

8%
OFF

Vertex Pharmaceuticals (VRTX) Set For Painless Gains After FDA …

3 weeks from now

3 hours ago · Vertex Pharmaceuticals shares surged 8% in post-market trading on January 30 after securing FDA approval for Journavx, also known as suzetrigine. The drug is the …

businessinsider.com

11%
OFF

Vertex Pharmaceuticals' Next Big Chapter? Vertex Stock Surges On ...

3 weeks from now

2 days ago · 1/31/2025 Vertex Pharmaceuticals won FDA approval for its non-opioid ... Vertex Dives 11% On A 'Worst-Case Scenario' For Its Non-Opioid Pain Drug; Stock Market Today: …

investors.com

9%
OFF

Is Vertex Pharmaceuticals A Buy Now That The FDA Approved Its …

3 weeks from now

1 day ago · Lately, one of America's leading pharmaceutical companies can't catch a break from Wall Street. Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) are down about 9% from a …

nasdaq.com

6%
OFF

Biotech Stock Rises After FDA Approves Non-Opioid Painkiller

3 weeks from now

2 days ago · Vertex Pharmaceuticals Inc (NASDAQ:VRTX) stock is up 6% at $465.02 at last glance, after the U.S. Food and Drug Administration (FDA) approved the biotech's new non …

schaeffersresearch.com

FAQs about Vertex Pharmaceuticals stock rises as FDA approves its pain pill Coupon?

Why did Vertex Pharmaceuticals stock surge ahead of Friday's market open?

Shares of Vertex Pharmaceuticals Inc. surged ahead of Friday’s market open after the Food and Drug Administration approved the company’s non-opioid pain treatment. It’s the first new class of pain treatment approved in more than 20 years, Vertex said in a press statement late Thursday. ...

Does Vertex Pharmaceuticals have FDA approval?

Vertex has been in business since the late 1980s. Six of the company’s other drugs currently have FDA approval, according to its website. A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug Administration (FDA). ...

Why did Vertex Pharmaceuticals stock surge 8 % after suzetrigine approval?

Vertex Pharmaceuticals shares surged 8 % in post-market trading on January 30 after securing FDA approval for Journavx, also known as suzetrigine. The drug is the company’s first-in-class non-opioid painkiller for moderate-to-severe acute pain. ...

Does Vertex Pharmaceuticals have a non-opioid painkiller?

U.S.-based Vertex Pharmaceuticals (VRTX) has secured approval from the FDA (Food and Drug Administration) for its long-awaited non-opioid painkiller. The approval of the company’s oral non-opioid pain medication, Journavx (suzetrigine), provides a groundbreaking alternative to addictive opioid painkillers. ...

Why is Vertex Pharmaceuticals (VRTX) stock rising?

Vertex Pharmaceuticals (VRTX) stock is rising following Food and Drug Administration (FDA) approval of Journavx, a non-opioid pain medication designed to treat moderate to severe acute pain. The new drug represents a potentially significant advancement in pain management, offering an alternative to traditional opioid-based treatments. ...

Does Vertex Pharmaceuticals have a suzetrigine pill?

The Food and Drug Administration approved the pill from Vertex Pharmaceuticals for acute pain that often occurs after surgery or injuries. This photo provided by Vertex Pharmaceuticals in January 2025 shows a tablet and bottle of the JOURNAVX (suzetrigine) medication. (Vertex Pharmaceuticals via AP) ...